CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $107.68 million. The enterprise value is -$53.77 million.
| Market Cap | 107.68M |
| Enterprise Value | -53.77M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 67.72 million shares outstanding. The number of shares has increased by 12.27% in one year.
| Shares Outstanding | 67.72M |
| Shares Change (YoY) | +12.27% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 1.19% |
| Owned by Institutions (%) | 48.55% |
| Float | 53.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 53.76 |
| PS Ratio | 1.06 |
| Forward PS | 1.15 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | -1.80 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17
| Current Ratio | 1.17 |
| Quick Ratio | 1.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.51 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -0.30% |
| Return on Capital (ROIC) | -3.32% |
| Revenue Per Employee | $843,450 |
| Profits Per Employee | -$4,742 |
| Employee Count | 120 |
| Asset Turnover | 0.47 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $3.89 million in taxes.
| Income Tax | 3.89M |
| Effective Tax Rate | 117.12% |
Stock Price Statistics
The stock price has increased by +1.27% in the last 52 weeks. The beta is 1.03, so CTMX's price volatility has been similar to the market average.
| Beta (1Y) | 1.03 |
| 52-Week Price Change | +1.27% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 27.12 |
| Average Volume (30 Days) | 929,246 |
Short Selling Information
The latest short interest is 3.59 million, so 5.31% of the outstanding shares have been sold short.
| Short Interest | 3.59M |
| Short Previous Month | 3.32M |
| Short % of Shares Out | 5.31% |
| Short % of Float | 6.68% |
| Short Ratio (days to cover) | 4.89 |
Income Statement
In the last 12 months, CTMX had revenue of $101.21 million and -$569,000 in losses. Loss per share was -$0.01.
| Revenue | 101.21M |
| Gross Profit | 101.21M |
| Operating Income | -6.48M |
| Pretax Income | 3.32M |
| Net Income | -569,000 |
| EBITDA | 9.23M |
| EBIT | 3.32M |
| Loss Per Share | -$0.01 |
Balance Sheet
The company has $175.43 million in cash and $13.97 million in debt, giving a net cash position of $161.45 million or $2.38 per share.
| Cash & Cash Equivalents | 175.43M |
| Total Debt | 13.97M |
| Net Cash | 161.45M |
| Net Cash Per Share | $2.38 |
| Equity / Book Value | -47.45M |
| Book Value Per Share | -0.70 |
| Working Capital | 27.02M |
Cash Flow
In the last 12 months, operating cash flow was -$56.04 million and capital expenditures -$840,000, giving a free cash flow of -$56.88 million.
| Operating Cash Flow | -56.04M |
| Capital Expenditures | -840,000 |
| Free Cash Flow | -56.88M |
| FCF Per Share | -$0.77 |
Margins
Gross margin is 100.00%, with operating and profit margins of -6.41% and -0.56%.
| Gross Margin | 100.00% |
| Operating Margin | -6.41% |
| Pretax Margin | 3.28% |
| Profit Margin | -0.56% |
| EBITDA Margin | 9.12% |
| EBIT Margin | 3.28% |
| FCF Margin | -56.19% |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.27% |
| Shareholder Yield | -12.27% |
| Earnings Yield | -0.53% |
| FCF Yield | -52.82% |
Analyst Forecast
The average price target for CTMX is $3.13, which is 96.86% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.13 |
| Price Target Difference | 96.86% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 3.14% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -4.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.04 |
| Piotroski F-Score | 2 |